+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells

Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells

Breast Cancer Research & Treatment 60(2): 129-134

An intrahepatic tumor model for metastatic breast cancer was generated in syngeneic mice by direct inoculation of JC cells, a murine mammary adenocarcinoma cell line. Intratumoral administration of a recombinant adenoviral vector expressing the murine Interleukin-12 (ADV-mIL-12) resulted in significant reduction in the tumor volume compared to control vector. Tumor regression was also evident on histopathologic analysis of the liver, where inflammatory changes as opposed to nuclear atypia predominated after IL-12 vector treatment. There was a significant prolongation in the long term survival of IL-12 treated animals, with complete tumor rejection in 40% of the animals. In vivo depletion studies using specific monoclonal antibodies against the various lymphocyte subsets showed a significant reduction in long term survival after natural killer (NK) cell depletion. This suggests that the NK cell is a critical effector in the antitumor effect mediated by IL-12. These results strongly support the potential role of gene mediated cytokine therapy for the treatment of metastatic breast cancer.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010182707

Download citation: RISBibTeXText

PMID: 10845275

DOI: 10.1023/a:1006318009608

Related references

Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model. Clinical and Experimental Immunology 159(1): 93-99, 2010

Anti-tumor natural killer cells are induced by herpes simplex virus thymidine kinase gene transduction and ganciclovir therapy in a mouse model of prostate cancer. Journal of Urology 159(5 Suppl. ): 8, 1998

Natural killer cells induced by Herpes Simplex virus thymidine kinase gene transduction and ganciclovir therapy are enhanced by interleukin-12 gene therapy in an orthotopic model of mouse prostate cancer. Journal of Urology 161(4 Suppl. ): 53, 1999

Protective anti-tumor immunity in a murine neuroblastoma model is induced by gene therapy with single chain interleukin-12, but not interleukin-2. Proceedings of the American Association for Cancer Research Annual Meeting (41): 195, 2000

Production of interleukin-2 EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity. Journal of Immunotherapy With Emphasis on Tumor Immunology 15(2): 119-128, 1994

Tumor Tropism of Intravenously Injected Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells and Their Gene Therapy Application in a Metastatic Breast Cancer Model. 2012

Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells. Cellular Immunology 108(2): 283-296, 1987

Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Cancer Gene Therapy 11(6): 397-407, 2004

Interleukin-15 gene therapy exclusively increases natural killer cells and suppresses tumor metastasis. FASEB Journal 18(4-5): Abst 775 8, 2004

Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. Cancer Research 60(22): 6457-6464, 2000

Interleukin-15-transferred cytokine-induced killer cells elevated anti-tumor activity in a gastric tumor-bearing nude mice model. Cell Biology International 40(2): 204-213, 2016

The chemokine CKbeta-11/MIP-3beta/ELC/Exodus III generates anti-tumor activity through natural killer cells and anti-tumor immunity through CD4+ cells. Blood 94(10 Suppl. 1 Part 1): 362a, 1999

The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity. Frontiers in Immunology 4: 490, 2013

The human interleukin 2 induced killer cell phenomenon lysis of natural killer resistant fresh solid tumor cells by interleukin 2 activated peripheral blood lymphocytes. Federation Proceedings 41(4): ABSTRACT 4014, 1982

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells. International Journal of Cancer 40(3): 365-371, 1987